Interleukin 2 up-regulates its own production.

Area of Science:

• Immunology
• Molecular Biology

Background:

• Anti-CD2 monoclonal antibodies (mAbs) like T11(2)+T11(3) can induce T cell proliferation without accessory cells or exogenous interleukin-2 (IL-2).
• Optimal T cell proliferation is dependent on specific anti-CD2 mAb combinations; some combinations, like anti-GT2+T11(1), result in suboptimal proliferation due to low IL-2 production.

Purpose of the Study:

• To investigate the effect of IL-2 on its own production in T cells stimulated with anti-CD2 mAbs.
• To explore the potential for exogenous IL-2 to enhance IL-2 production in a specific T cell subset.

Main Methods:

• Stimulation of cloned TA4 helper T cells with anti-GT2+T11(1) mAbs.
• Preincubation of TA4 cells with varying concentrations of recombinant IL-2 (rIL-2) prior to mAb stimulation.
• Measurement of IL-2 activity in culture supernatants.
• Confirmation of findings through analysis of IL-2 mRNA expression.

Main Results:

• Anti-GT2+T11(1) mAb stimulation alone induced only marginal IL-2 production in TA4 cells.
• Preincubation with rIL-2 significantly increased IL-2 activity in a dose-dependent manner (5-50 IU/ml).
• This enhancement was not attributed to rIL-2 carryover, reduced IL-2 consumption, or an increased number of IL-2-producing cells.
• IL-2 mRNA levels also confirmed that rIL-2 up-regulates its own production upon anti-CD2 mAb activation.

Conclusions:

• Exogenous IL-2 can up-regulate its own production by T cells when they receive a second signal from anti-CD2 mAbs.
• This suggests an autocrine feedback loop where IL-2 amplifies its own synthesis in activated T cells.
• Understanding this mechanism is crucial for modulating T cell responses in immunological contexts.